ClearPoint Neuro
CLPT
78 hedge funds and large institutions have $76.5M invested in ClearPoint Neuro in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 22 closing their positions.
101% more capital invested
Capital invested by funds: $38M → $76.5M (+$38.5M)
46% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $695K
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
1% less ownership
Funds ownership: 25.73% → 24.73% (-1%)
9% less funds holding
Funds holding: 86 → 78 (-8)
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$2.09M |
| 2 |
D.E. Shaw & Co
New York
|
+$1.4M |
| 3 |
CCM
Conway Capital Management
Burbank,
California
|
+$1.35M |
| 4 |
Citigroup
New York
|
+$763K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$756K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.82M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$1.22M |
| 3 |
Renaissance Technologies
New York
|
-$1.16M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$949K |
| 5 |
Goldman Sachs
New York
|
-$933K |
CLPT Hedge Fund Activity: Q3 2024 in Review
78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2024, worth a combined $76.5M — up 101% from $38M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of CLPT and 14 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 21 added.
The largest buyer was Marshall Wace, adding an estimated $2.09M. The largest seller was Millennium Management, cutting an estimated $1.82M.
- 78 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2024, down from 86 in Q2 2024.
- Funds reported $76.5M of ClearPoint Neuro stock for Q3 2024, up 101% quarter-over-quarter.
- 14 funds opened new ClearPoint Neuro positions in Q3 2024 and 22 closed out, a net change of -8 holders.
- The largest ClearPoint Neuro buyer in Q3 2024 was Marshall Wace, an estimated $2.09M added.
- The largest ClearPoint Neuro seller in Q3 2024 was Millennium Management, an estimated $1.82M sold.
Based on aggregated 13F filings for Q3 2024.